Wang-Gang Zhang
Department of Hematology and Oncology
The Second Affiliated Hospital
Xi'an JiaoTong University
Xi'an
China
Name/email consistency: high
- Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia. Zhang, W.G., Wang, F.X., Chen, Y.X., Cao, X.M., He, A.L., Liu, J., Ma, X.R., Zhao, W.H., Liu, S.H., Wang, J.L. Am. J. Hematol. (2008)
- A phase-I clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2, GM-CSF, and IL-6. Zhang, W.G., Liu, S.H., Cao, X.M., Cheng, Y.X., Ma, X.R., Yang, Y., Wang, Y.L. Leuk. Res. (2005)